Doh Yu Hwang

Clinical usefulness of serum and plasma vascular endothelial growth factor in cancer patients: which is the optimal specimen?

J K Lee, Yuan Hong, Doh Yu Hwang et al. · International Journal of Oncology · 2000 · 96 citations

Pathology, Cancer Patients, Thrombosis +21

ULK1 inhibition as a targeted therapeutic strategy for FLT3-ITD-mutated acute myeloid leukemia

Doh Yu Hwang, Ju-In Eom, Ji Eun Jang et al. · Journal of Experimental & Clinical Cancer Research · 2020 · 38 citations · Full text

Risk Factors for Progression from Cytomegalovirus Viremia to Cytomegalovirus Disease after Allogeneic Hematopoietic Stem Cell Transplantation

Ji Eun Jang, Shin Young Hyun, Yun Deok Kim et al. · Biology of Blood and Marrow Transplantation · 2011 · 34 citations · Full text

Cytomegalovirus Disease, Cmv Viremia, Immunology +17

Serum microRNA-21 as a Potential Biomarker for Response to Hypomethylating Agents in Myelodysplastic Syndromes

Yundeok Kim, June‐Won Cheong, Yeo-Kyeoung Kim et al. · PLoS ONE · 2014 · 33 citations · Full text

Epigenetic Change, Immunology, Potential Biomarker +19

The Modified Glasgow Prognostic Scores as a Predictor in Diffuse Large B Cell Lymphoma Treated with R-CHOP Regimen

Yundeok Kim, Soo‐Jeong Kim, Doh Yu Hwang et al. · Yonsei Medical Journal · 2014 · 25 citations · Full text